Log In
Wednesday 19th June 2019

Key to breast cancer treatment found in overactive gene

2nd June 2011

Scientists have said that they believe a network of overactive genes drives one of the deadliest forms of breast cancer and that the discovery could lead to new therapies for ‘triple-negative’ cancers, which affect around one in seven women with the disease and fail to respond to most treatments.

The charity Breakthrough Breast Cancer said the research from the Dana-Faber Cancer Institute in Boston, US, was “very exciting” and that new treatments for triple-negative breast cancer were urgently needed. The research is reported in the Journal of Clinical Investigation.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019